Skin Cancer Diagnostics Market –Worldwide Industry Growth Report
A new report “Global Skin Cancer Diagnostics Market Research Report - Industry Analysis and Forecast To 2019” offered by DecisionDatabases.com gives an analytical study of the market, its value chain, latest trends, forecasts, innovation, drivers, and restraints. The historical study from 2015 helps in a better understanding of the market. The report also details about the market players who hold a dominating position in the global business scenario. The increasing incidences of skin cancers globally, rising technological advancements and growing awareness with improving healthcare facilities are major growth drivers, which are expected to augment demand for skin care diagnostics market over the coming years.
Skin cancers are one of the major prevailing cancers across the globe. The major reason for skin cancer is exposure to the UV rays from the sun. There are various kinds of skin cancers such as melanoma forms in melanocytes, basal cell carcinoma forms in the outer layer of the epidermis, squamous cell carcinoma forms in the flat cells of the dermis and neuroendocrine carcinoma forms in the neuroendocrine cells. In addition, increasing supportive government initiatives will further boost the market growth in the near future. Availability of a large number of diagnostics solutions and increasing adoption of premium-priced product are anticipated to fuel market demand in the forthcoming years. However, high cost associated with the diagnostics, inadequate patient base, certain regulatory issues and lack of awareness in some emerging economies are major restraints, which may restrict the growth of skin cancer diagnostics market.
The global skin cancer diagnostics market has been segmented based on the type of cancer into basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. Furthermore, the skin cancer diagnostics market has been segmented based on products, into dermatoscopes, microscopes, imaging techniques, and optical coherence tomography scanners.
North America is the biggest market for skin cancer diagnostics and is expected to continue its dominance over the forecast period on account of growing prevalence of skin cancer, rising geriatric population base and availability of technologically advanced treatment facilities, especially in the USA. Asia Pacific is a fastest growing market for skin cancer diagnostics and is projected to grow at a double-digit rate in the study period owing to the burgeoning population, high disposable income, improving medical facilities and rising health awareness particularly in the India, China, and Japan. European market also shows growth prospects owing to the recovery of economy crisis, high treatment rates and market penetration of premium drugs.
The major players covered in the report include Agilent Technologies, Inc., Biolitech AG, GE Healthcare, Leica Microsystems, Michelson Diagnostics Ltd., and Toshiba Medical Systems.
In Nov 2013, Myriad Genetics, Inc. has launched Myriad myPath™ Melanoma, an advance diagnostic test to efficiently separate malignant melanoma from benign pigmented skin lesions.
In July 2015, Biocept, Inc. a leading molecular diagnostics company has commercialized and developed liquid biopsies, a skin cancer diagnostics test to progress the treatment and detection and of cancer.
In Sept 2014, Vela Diagnostics launched the “Sentosa SQ Melanoma Panel” for NGS (Next-Generation Sequencing)-based gene sequence variant identification and detection.
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
For more details:
E-Mail: [email protected]
Phone: +91 99 28 237112